About this trial

The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.

Eligibility criteria

Qualifiers

Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Avacopan

Treatment groups

250 Participants
are divided into 1 treatment group

Locations

1
Research site Multiple Locations Japan

Sponsors and collaborators

Kissei Pharmaceutical Co., Ltd.

Lead sponsor